BioForce Nanosciences announced today the placement of its cutting-edge Nano eNabler(TM) molecular printer at four prestigious colleges and universities in the United States and Canada as part of its pilot placement programme. This programme consists of the placement of the Company’s patented Nano eNabler(TM) device at approximately 20 key centres of research excellence, where it is operated by entrepreneurial researchers often termed “early adopters”. This programme is designed to position BioForce as a principal provider of practical tools and technologies for the nano/life sciences market and promote the conversion of these placements into sales.

Recently, the instrument has been installed in four locations: (1) California Institute for Quantitative Biomedical Research (QB3) at the University of California under the supervision of Tejal Desai, Ph.D; (2) the Department of Physics at McGill University in Montreal under the supervision of Peter Grutter, Ph.D.; (3) The Biofunctional Photonics Group at The Rowland Institute, Harvard University, under the supervision of Frank Vollmer, Ph.D. and Ozgur Sahin, Ph.D.; and (4) Boston University’s Centre for Nanoscience and Nanobiotechnology under the supervision of Dr. Mario Cambodi.

These placements are part of a larger BioForce Nanosciences, Inc. pilot programme to gather feedback on the performance of the Nano eNabler system and facilitate real-world applications of the instrument. BioForce Product Manager, Michael Lynch, says “The goal of the BioForce pilot placement programme is to seek out groups of innovators working in micro and nanotechnologies and provide them with early access to a new tool for their research. Their application development efforts and feedback concerning the features and performance of the Nano eNabler are invaluable to us. The supportive mission of all these institutions toward the industry makes this a perfect fit and we are excited about the prospects for these mutually beneficial partnerships.”

BioForce’s Kerry Frey, chief operating officer, says, “This instrument allows researchers to create patterns of molecules that direct cell growth, functionalise nano/biosensors and create new therapeutic microdevices. As we move into 2007, BioForce is poised to help researchers discover additional uses for the Nano eNabler technology.” By the end of 2006, BioForce Nanosciences anticipates having shipped 20 systems.

Information on the institutions where recent placements have taken place:

California Institute for Quantitative Biomedical Research (QB3) at the University of California in San Francisco, CA-studies focus on the design, fabrication, and making the essential connections between structure and function of biomolecules at the micro/nanoscale to human physiology and pathophysiology at the macroscale.

Department of Physics at McGill University in Montreal, QC Canada-McGill University’s Department of Physics offers a rich research environment that includes the availability of advanced probes and sensors, fast imaging and correlation spectroscopies, and the access to atomic manipulation and microfabrication facilities.

The Biofunctional Photonics Group at The Rowland Institute, Harvard University, Cambridge, MA-the Biofunctional Photonics Group interfaces applied physics with biochemistry to design and fabricate photonic and microfluidic circuits for biodetection, manipulation, spectroscopy, and biological analysis.

Boston University’s Centre for Nanoscience and Nanobiotechnology advances academic and technological research and development by extending discoveries in nanoscale materials and platforms toward applications that examine and seek to understand and manipulate biological systems.

Powered by Joomla Tags